Classic Nephropathic Cystinosis as an Adult Disease

JAMA: The Journal of the American Medical Association

Volumn 270, Issue 18, 1993, Pages 2200-2204

  Theodoropoulos, Demetrios S ^a   Krasnewich, Donna ^b   Gahl, William A ^b   Kaiser Kupfer, Muriel I ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTAFOS; CYSTINE; MERCAPTAMINE; THYROID HORMONE;

ADOLESCENT; ADULT; ARTICLE; BRAIN CALCIFICATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CYSTINOSIS; DYSPHAGIA; FEMALE; GRAFT SURVIVAL; GROWTH RETARDATION; HORMONE SUBSTITUTION; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MALE; MYOPATHY; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

ADULT; CENTRAL NERVOUS SYSTEM DISEASES; COHORT STUDIES; COST OF ILLNESS; CYSTEAMINE; CYSTINOSIS; ENDOCRINE DISEASES; FEMALE; GRAFT SURVIVAL; GROWTH; HUMAN; KIDNEY TRANSPLANTATION; MALE; MUSCULAR DISEASES; SURVIVAL ANALYSIS; VISUAL ACUITY;

EID: 0027514879     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1993.03510180070036     Document Type: Article

References (28)

1. Gahl WA, Bashan N, Tietze F, Bernardini I, Schulman JD. Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science. 1982;217:1263-1265.
2. Gahl WA, Tietze F, Bashan N, Steinherz R, Schulman JD. Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes. J Biol Chem. 1982;257:9570-9575.
3. Gahl WA. Cystinosis coming of age. Adv Pediatr. 1986;33:95-126.
4. Gahl WA, Renlund M, Thoene JG. Lysosomal transport disorders: cystinosis and sialic acid storage disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw-Hill International Book Co; 1989:2619-2647.
5. Krasnewich DM, Gahl WA. Cystinosis: a treatable lysosomal storage disease. Endocrinologist. 1991;1: 111-118.
6. Gretz N, Manz F, Augustin R, et al. Survival time in cystinosis: a collaborative study. Proc Eur Dial Transplant Assoc. 1983;19:582-589.
7. Gahl WA, Reed GF, Thoene JG, et al. Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med. 1987;316:971-977.
8. Gahl WA, Schneider JA, Schulman JD, Thoene JG, Reed GF. Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine. Pediatr Nephrol. 1990;4:129-135.
9. Markello TC, Bernardini IM, Gahl WA. Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med. 1993;328:1157-1162.
10. Thoene JG, Oshima RG, Crawhall JC, Olson DL, Schneider JA. Cystinosis: intracellular cystine depletion by aminothiols in vitro and in vivo. J Clin Invest. 1976;58:180-189.
11. Smolin LA, Clark KF, Thoene JG, Gahl WA, Schneider JA. A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis. Pediatr Res. 1988;23:616-620.
12. Gahl WA, Kaiser-Kupfer MI. Complications of nephropathic cystinosis after renal failure. Pediatr Nephrol. 1987;1:260-268.
13. Kaiser-Kupfer MI, Caruso RC, Minkler DS, Gahl WA. Long-term ocular manifestations in nephropathic cystinosis. Arch Ophthalmol. 1986;104:706-711.
14. Jonas AJ, Conley SB, Marshall R, Johnson RA, Marks M, Rosenberg H. Nephropathic cystinosis with central nervous system involvement. Am J Med. 1987;83:966-970.
15. Fink JK, Brouwers P, Barton N, et al. Neurologic complications in long-standing nephropathic cystinosis. Arch Neurol. 1989;46:543-548.
16. Gahl WA, Dalakas MC, Charnas L, et al. Myopathy and cystine storage in muscles in a patient with nephropathic cystinosis. N Engl J Med. 1988; 319:1461-1464.
17. Oshima RG, Willis RC, Furlong CE, Schneider JA. Binding assays for amino acids: the utilization of a cystine-binding protein from Escherichia coli for the determination of acid-soluble cystine in small physiological samples. J Biol Chem. 1974;249:6033-6039.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. JAm Stat Assoc. 1958; 53:457-481.
19. Thorogood J, van Houwelingen JC, van Rood JJ, Zantvoort FA, Schreuder GMT, Persijn GG. Factors contributing to long-term kidney graft survival in Eurotransplant. Transplantation. 1992;54:152-158.
20. Fivush B, Green OC, Porter CC, Balfe JW, O'Regan S, Gahl WA. Pancreatic endocrine insufficiency in posttransplant cystinosis. AJDC. 1987;141: 1087-1089.
21. Sonies BC, Ekman EF, Andersson HC, et al. Swallowing dysfunction in nephropathic cystinosis. N Engl J Med. 1990;323:565-570.
22. Vogel DG, Malekzadeh MH, Cornford ME, Schneider JA, Shields WD, Vinters HV. Central nervous system involvement in nephropathic cystinosis. J Neuropathol Exp Neurol. 1990;49:591-599.
23. Fivush B, Flick JA, Gahl WA. Pancreatic exocrine insufficiency in a patient with nephropathic cystinosis. J Pediatr. 1988;112:49-51.
24. Chan AM, Lynch MJ, Bailey JD, Ezrin C, Fraser D. Hypothyroidism in cystinosis: a clinical, endocrinologic and histologic study involving sixteen patients with cystinosis. Am J Med. 1970;48:678-692.
25. Kaiser-Kupfer MI, Gazzo MA, Datiles MB, Caruso RC, Kuehl EM, Gahl WA. A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis. Arch Ophthalmol. 1990; 108:689-693.
26. Gahl WA, Schneider JA, Thoene JG, Chesney R. Course of nephropathic cystinosis after age 10 years. J Pediatr. 1986;109:605-608.
27. Gahl WA, Charnas LR, Markello TC, Bernardini IM, Ishak KG, Dalakas MC. Parenchymal organ cystine depletion with long-term cysteamine therapy. Biochem Med Metab Biol. 1992;48:275-285.
28. Kaiser-Kupfer MI, Fujikawa L, Kuwabara T, Jain S, Gahl WA. Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. N Engl J Med. 1987;316:775-779.